Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making

References

• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-5
   PubMed Web of Science ®Google Scholar
• Weisbord SD, Whittle J, Brooks RC. Is warfarin really underused in patients with atrial fibrillation? J Gen Intern Med 2001;16:743-9
   PubMed Web of Science ®Google Scholar
• Cohen N, Almoznino-Sarafian D, Alon I, et al. Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. Stroke 2000;31:1217-22
   PubMed Web of Science ®Google Scholar
• Bungard TJ, Ghali WA, Teo KK, et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-6
   PubMed Web of Science ®Google Scholar
• Eckman MH. Patient-centered decision making: a view of the past and a look toward the future. Med Decis Making 2001;21:241-7
   PubMed Web of Science ®Google Scholar
• You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141(2 Suppl):e531-75S
   Web of Science ®Google Scholar
• McNeil BJ, Pauker SG, Sox JHC, Tversky A. On the elicitation of preferences for alternative therapies. N Engl J Med 1982;306:1259-62
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57
   PubMed Web of Science ®Google Scholar
• Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-52
   PubMed Web of Science ®Google Scholar
• Elwyn G, Edwards A, Eccles M, Rovner D. Decision analysis in patient care. Lancet 2001;358:571-4
   PubMed Web of Science ®Google Scholar
• Plante DA, Kassirer JP, Zarin DA, Pauker SG. Clinical decision consultation service. Am J Med 1986;80:1169-76
   PubMed Web of Science ®Google Scholar
• Pell I, Dowie J, Clarke A, et al. Development and preliminary evaluation of a clinical guidance programme for the decision about prophylactic oophorectomy in women undergoing a hysterectomy. Qual Saf Health Care 2002;11:32-8; discussion 38-9
   PubMed Web of Science ®Google Scholar
• Robinson A, Thomson RG. The potential use of decision analysis to support shared decision making in the face of uncertainty: the example of atrial fibrillation and warfarin anticoagulation. Qual Health Care 2000;9:238-44
   PubMedGoogle Scholar
• Short D, Frischer M, Bashford J. The development and evaluation of a computerised decision support system for primary care based upon ‘patient profile decision analysis'. Inform Prim Care 2003;11:195-202
   PubMedGoogle Scholar
• Brothers TE, Robison JG, Elliott BM. Prospective decision analysis for peripheral vascular disease predicts future quality of life. J Vasc Surg 2007;46:701-8; discussion 708
   PubMed Web of Science ®Google Scholar
• Dowie J, Wildman M. Choosing the surgical mortality threshold for high risk patients with stage Ia non-small cell lung cancer: insights from decision analysis. Thorax 2002;57:7-10
   PubMed Web of Science ®Google Scholar
• Montgomery AA, Harding J, Fahey T. Shared decision making in hypertension: the impact of patient preferences on treatment choice. Fam Pract 2001;18:309-13
   PubMed Web of Science ®Google Scholar
• Laupacis A, Hing M, O'Connor A, Biggs J, Hart R. A randomized trial of an audiobooklet decision aid in patients with atrial fibrillation. 14th Annual Meeting of the International Society for Technology Assessment in Health Care, Ottawa, Ontario, Canada, 1998
   Google Scholar
• Man-Son-Hing M, O'Connor AM, Drake E, et al. The effect of qualitative vs. quantitative presentation of probability estimates on patient decision-making: a randomized trial. Health Expect 2002;5:246-55
   PubMedGoogle Scholar
• Protheroe J, Fahey T, Montgomery AA, Peters TJ. Effects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis. West J Med 2001;174:311-15
   PubMedGoogle Scholar
• Robinson A, Thomson R, Parkin D, et al. How patients with atrial fibrillation value different health outcomes: a standard gamble study. J Health Serv Res Policy 2001;6:92-8
   PubMedGoogle Scholar
• Thomson RG, Eccles MP, Steen IN, et al. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial. Qual Saf Health Care 2007;16:216-23
   PubMed Web of Science ®Google Scholar
• van der Weijden T, Legare F, Boivin A, et al. How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol. Implement Sci 2010;5:1-9
   PubMedGoogle Scholar
• van der Weijden T, Pieterse AH, Koelewijn-van Loon MS, et al. How can clinical practice guidelines be adapted to facilitate shared decision making? A qualitative key-informant study. BMJ Qual Saf 2013;22:855-63
   Web of Science ®Google Scholar
• National Institute for Health and Healthcare Excellence. Atrial Fibrillation: the Management of Atrial Fibrillation, 2014 http://www.nice.org.uk/guidance/cg180/resources/
   Google Scholar
• Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011;342:d124
   PubMed Web of Science ®Google Scholar
• van Walraven C, Hart RG, Connolly S, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation. The Atrial Fibrillation Investigators. Stroke 2009;40:1410-16
   Google Scholar
• Sherman DG, Kim SG, Boop BS, et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med 2005;165:1185-91
   PubMed Web of Science ®Google Scholar
• Penado S, Cano M, Acha O, et al. Stroke severity in patients with atrial fibrillation. Am J Med 2002;112:572-4
   PubMed Web of Science ®Google Scholar
• Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012;33:1500-10
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67
   PubMed Web of Science ®Google Scholar
• Wintzen AR, Tijssen JG. Subdural hematoma and oral anticoagulant therapy. Arch Neurol 1982;39:69-72
   PubMed Web of Science ®Google Scholar
• Singer DE, Chang Y, Fang MC, et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009;151:297-305
   PubMed Web of Science ®Google Scholar
• Fang MC, Go AS, Hylek EM, et al. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 2006;54:1231-6
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke 2005;36:1801-7
   PubMed Web of Science ®Google Scholar
• He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998;280:1930-5
   PubMed Web of Science ®Google Scholar
• van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288:2441-8
   PubMed Web of Science ®Google Scholar
• Wintzen AR, de Jonge H, Loeliger EA, Bots GT. The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol 1984;16:553-8
   PubMed Web of Science ®Google Scholar
• Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995;26:1471-7
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med 1996;156:409-16
   PubMedGoogle Scholar
• Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501
   PubMed Web of Science ®Google Scholar
• Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004;164:880-4
   PubMed Web of Science ®Google Scholar
• Fang MC, Go AS, Chang Y, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007;120:700-5
   PubMed Web of Science ®Google Scholar
• Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902
   PubMed Web of Science ®Google Scholar
• Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 1996;156:1829-36
   PubMed Web of Science ®Google Scholar
• Lai SM, Alter M, Friday G, Sobel E. Prognosis for survival after an initial stroke. Stroke 1995;26:2011-15
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2011;138:1093-100
   Web of Science ®Google Scholar
• Elwyn G, Kreuwel I, Durand MA, et al. How to develop web-based decision support interventions for patients: a process map. Patient Educ Couns 2010;82:260-5
   PubMed Web of Science ®Google Scholar
• Martin AJ, Glasziou PP, Simes RJ, Lumley T. A comparison of standard gamble, time trade-off, and adjusted time trade-off scores. Int J Technol Assess Health Care 2000;16:137-47
   PubMed Web of Science ®Google Scholar
• Littenberg B. Gambles. In: Kattan M, editor. Encyclopedia of Medical Decision Making. Los Angeles: Sage Reference Publications, 2009:527-9
   Google Scholar
• Murtagh MJ, Thomson RG, May CR, et al. Qualitative methods in a randomised controlled trial: the role of an integrated qualitative process evaluation in providing evidence to discontinue the intervention in one arm of a trial of a decision support tool. Qual Saf Health Care 2007;16:224-9
   PubMed Web of Science ®Google Scholar
• Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996;348:423-8
   PubMed Web of Science ®Google Scholar
• Green C, Brazier J, Deverill M. Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics 2000;17:151-65
   PubMed Web of Science ®Google Scholar
• Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1-30
   PubMed Web of Science ®Google Scholar
• Jansen SJ, Stiggelbout AM, Wakker PP, et al. Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff. Med Decis Making 1998;18:391-9
   PubMed Web of Science ®Google Scholar
• Lalonde L, Clarke AE, Joseph L, Grover SA. Conventional and chained standard gambles in the assessment of coronary heart disease prevention and treatment. Canadian Collaborative Cardiac Assessment Group. Med Decis Making 1999;19:149-56
   PubMed Web of Science ®Google Scholar
• Wright DR, Wittenberg E, Swan JS, et al. Methods for measuring temporary health states for cost–utility analyses. Pharmacoeconomics 2009;27:713-23
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001;323:1218-22
   PubMed Web of Science ®Google Scholar
• Gonzales E, Eckman M, Pauker S. ‘Gambler’: a computer workstation for patient utility assessment. Med Decis Making 1992;12:350
   Google Scholar
• Bungard TJ, Ghali WA, Teo KK, et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-6
   PubMed Web of Science ®Google Scholar
• Monette J, Gurwitz JH, Rochon PA, Avorn J. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners [see comments]. J Am Geriatr Soc 1997;45:1060-5
   PubMed Web of Science ®Google Scholar
• Lip GY, Zarifis J, Watson RD, Beevers DG. Physician variation in the management of patients with atrial fibrillation. Heart 1996;75:200-5
   PubMed Web of Science ®Google Scholar
• American College of Physicians Foundation. Afib - What You and Your Family Should Know. American College of Physicians Foundation. 2011. http://www.acponline.org/patients_families/products/brochures/afib_booklet.pdf
   Google Scholar
• Alberts MJ. Assessing Stroke and Bleeding Risk in Atrial Fibrillation - Consensus Statement on Appropriate Anticoagulant Use. The Alliance for Aging Research, 2012
   Google Scholar
• United States House of Representatives, House Resolution 295 (112th): promoting increased awareness, diagnosis, and treatment of atrial fibrillation. In: Ho, editor. Representatives. Washington, DC, 2011
   Google Scholar
• Man-Son-Hing M, Gage BF, Montgomery AA, et al. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making. Med Decis Making 2005;25:548-59
   PubMed Web of Science ®Google Scholar
• Man-Son-Hing M, Laupacis A, O'Connor AM, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA 1999;282:737-43
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Street RL Jr, Fried TR. Development of a tool to improve the quality of decision making in atrial fibrillation. BMC Med Inform Decis Mak 2012;11:59
   Google Scholar
• Howitt A, Armstrong D. Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ 1999;318:1324-7
   PubMed Web of Science ®Google Scholar
• Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 2000;320:1380-4
   PubMed Web of Science ®Google Scholar
• Thomson R, Parkin D, Eccles M, et al. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 2000;355:956-62
   PubMed Web of Science ®Google Scholar
• Thomson R, Robinson A, Greenaway J, Lowe P. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Qual Health Care 2002;11:25-31
   Google Scholar
• Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991;22:312-18
   PubMed Web of Science ®Google Scholar
• Rimer BK, Halabi S, Sugg Skinner C, et al. The short-term impact of tailored mammography decision-making interventions. Patient Educ Couns 2001;43:269-85
   PubMed Web of Science ®Google Scholar
• O'Connor AM, Rostom A, Fiset V, et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ 1999;319:731-4
   PubMed Web of Science ®Google Scholar
• Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients' desire for autonomy: decision making and information-seeking preferences among medical patients. J Gen Intern Med 1989;4:23-30
   PubMed Web of Science ®Google Scholar
• Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996;16:58-64
   PubMed Web of Science ®Google Scholar
• Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70
   PubMed Web of Science ®Google Scholar
• Eckman MH, Singer DE, Rosand J, Greenberg SM. Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 2011;4:14-21
   PubMed Web of Science ®Google Scholar
• Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151:713-19
   PubMed Web of Science ®Google Scholar
• Grossman EG. Patient Protection and Affordable Care Act Health-Related Portions of the Health Care and Education Reconciliation Act of 2010. United States House of Representatives, Washington, DC, 2010
   Google Scholar
• Centers for Medicare and Medicaid Services. Medicare Shared Savings Program: Accountable Care Organizations. Federal Register. 2011:76:67802-990
   Google Scholar
• Elwyn G, O'Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One 2009;4:e4705
   PubMed Web of Science ®Google Scholar